LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Study: Vitamin C No Impact on Complex Pain Syndrome
Large Joints and Extremities

Study: Vitamin C No Impact on Complex Pain Syndrome

June 6, 2019 2 min read Premium comments

Advertisement

Study: Vitamin C No Impact on Complex Pain Syndrome
Source: Pixabay
Secondary#crps#nealchen#vitaminc

A group of researchers has determined that vitamin C does not reduce the incidence of Complex Regional Pain Syndrome (CRPS) and therefore facilitate recovery from distal radius fracture and that attention should be paid to reducing pain interference (nurturing more adaptive coping strategies) to facilitate patient recovery.

" data-large-file="https://i0.wp.com/ryortho.com/wp-content/uploads/2019/06/StudyVitaminC_NealChenMD_WEB.jpg?fit=135%2C145&ssl=1" src="https://i0.wp.com/ryortho.com/wp-content/uploads/2019/06/StudyVitaminC_NealChenMD_WEB.jpg?resize=135%2C145&ssl=1" alt="" width="135" height="145">
Neal Chen, M.D.

The results of this study were presented by Sezai Özkan, M.D., Teun Teunis, M.D., Neal Chen, M.D., and David. C. Ring, M.D. at this year’s American Academy of Orthopaedic Surgeons (AAOS) annual meeting. The presentation was titled “The Effect of Vitamin C on Finger Stiffness After Fracture of the Distal Radius: A Double-Blind Placebo-Controlled Randomized Trial.”

This pragmatic, double-blind, randomized, placebo-controlled, non-crossover study examined adult patients who presented to a level 1 trauma center in an urban city in the United States within two weeks of a distal radius fracture.

The study utilized computer-based block randomization. Patients were allocated to receive either 500 mg vitamin C or a placebo once daily. There were 67 patients in each group. All research personnel and participants were blinded to group allocation, except for the pharmacist preparing the medication.

The main outcome was distance between fingertip and distal palmar crease six weeks after the fracture. Ten patients from the vitamin C and five from the placebo group were unavailable for follow up. The researchers used strict intention-to-treat and multiple linear imputation to address missing data.

There was no significant difference in distance to distal palmar crease between people taking vitamin C or placebo. Pain interference was the only factor associated with greater functional limitations at six weeks after fracture.

OTW spoke with Neal C. Chen, M.D., interim chief, Hand & Arm Center at Massachusetts General Hospital about why the researchers decided to conduct the study. Chen told OTW, “There has been some question of whether or not the routine use of vitamin C with distal radius fractures reduces the incidence of CRPS [complex regional pain syndrome]. The issues around it are that prior studies have relied on very soft criteria for determining who has CRPS after distal radius fractures.”

Advertisement

Chen continued, “We decided to run a study—a prospective randomized control study—on patients who had a distal radius fracture to see if patients who received vitamin C had more stiffness than patients who did not. Stiffness being the surrogate for CRPS.”

Dr. Chen’s most important takeaway is that, “We’ve learned that vitamin C is not helpful. We want to get it out there that routine administration of vitamin C after a wrist fracture does not help. There are resources that can be allocated in different ways…. We want people to have good care, proficient care, and care that is cost-effective.”

The study has been accepted for forthcoming publication in Clinical Orthopedics and Research.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy